Delivery Order SPE2DB20D1109-SPE2DB24FN04M
Award Date 11/8/23
Potential Completion Date 11/9/23
Potential Value $2.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,265.40, is for the delivery of the ROTATEQ vaccine, a 2-milliliter treatment. This is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the ROTATEQ vaccine in 2 mL doses. The contract has a ceiling value of $1,265.40 and an ultimate completion date of May 16, 2023. This is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order valued at $1,300.85 for the supply of the ROTATEQ vaccine. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the U.S. Department of Defense. The contract is a firm fixed price delivery order with an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization and leading global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,664.10, is a delivery order for the ROTATEQ vaccine in 2 milliliter vials. The contract has an ultimate completion date of January 28, 2025 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
- This federal contract award, valued at $2,751.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,558,328 doses of the ROTATEQ vaccine, a rotavirus vaccine, with a completion date of May 10, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office Division, is a major supplier of...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of the ROTATEQ vaccine, a 2-milliliter dose of the rotavirus vaccine. The $2,012.76 firm-fixed price delivery order has an ultimate completion date of December 10, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,009.64 Delivery Order is for the supply of the ROTATEQ vaccine, a 2 mL dosage. The contract is a Firm Fixed Price arrangement with a completion date of May 30, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through...
- This federal contract award, valued at $1,469.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the ROTATEQ VACCINE 2ML product, with a performance period ending on January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ROTATEQ vaccine, a rotavirus vaccine, with a ceiling value of $10,549.02. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This federal contract award, valued at $1,958.62, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the ROTATEQ vaccine, a 2ml dosage. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...